J, T., K, S., I, E., & TM, P. (2022). ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Annals of surgical oncology, 29(12), 7615. https://doi.org/10.1245/s10434-022-12105-y
Chicago Style (17th ed.) CitationJ, Toyoda, Sahara K, Endo I, and Pawlik TM. "ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium." Annals of Surgical Oncology 29, no. 12 (2022): 7615. https://doi.org/10.1245/s10434-022-12105-y.
MLA (9th ed.) CitationJ, Toyoda, et al. "ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium." Annals of Surgical Oncology, vol. 29, no. 12, 2022, p. 7615, https://doi.org/10.1245/s10434-022-12105-y.